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 Sir 
Noroviruses have been recognised as an important cause of chronic 
gastroenteritis in immunocompromised patients.1-4 Prolonged norovirus illness has 
been reported in persons who are immunosuppressed as a result of 
immunosuppressive therapy.1 Norovirus shedding in stool has been detected by 
PCR up to 56 days in immunocompetent patients.2 In immunocompromised patients 
this can be longer; Ludwig et al., (2008) reported norovirus detection up to 433 days 
in paediatric cancer patients.3 Roddie et al., (2009) reported that 18% of patients 
who underwent allogeneic hematopoietic stem-cell transplantation contracted 
norovirus over a 1-year period.4 Here we describe ongoing transmission of norovirus 
GII from a chronic carrier on a clinical haematology ward at Queen Elizabeth 
Hospitals, Birmingham (QEHB), UK. We also describe use of a norovirus PCR to 
assess for environmental clearance of the virus. 
 
A patient with acute myeloid leukaemia was admitted to the clinical 
haematology unit at QEHB in January 2018 due to manifestations of graft versus 
host disease. During this admission, the patient acquired norovirus GII due to an 
outbreak on the ward, and was then isolated in a single room. The patient 
subsequently had multiple stays on the ward during these 10 months (5 inpatient 
stays in total), during which time he had persistent diarrhoea and continued to test 
positive for norovirus by PCR. On each admission the patient was isolated in a 
different side room (either balanced pressure or positive pressure) with en-suite toilet 
facilities, and on discharge an infectious clean of the room was routinely undertaken.   
However, despite these measures a total of 14 patients acquired confirmed 
norovirus GII infection during the times that this patient was on the ward. 
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Additionally, 3 staff members developed norovirus-like illnesses, although these 
cases did not undergo norovirus PCR testing. Epidemiological data indicated that the 
chronic carrier was the only common factor on each occasion, suggesting this was 
the index patient for these transmissions. In two instances the patient immediately 
admitted into the room vacated by the index patient acquired norovirus infection. 
Molecular typing also suggested transmission of the same strain of norovirus (GII 
genotype 4 prototype strain Sydney/2012/Australia). 
 
In response to the evidence of ongoing transmission from the chronic carrier, 
in October 2018 the positive pressure side room that had been occupied by the 
chronic carrier patient for 29 days was environmentally sampled post-discharge. 
Before sampling the room underwent enhanced cleaning, comprising detergent/ 
disinfectant (1,000ppm; Chlor-Clean, Guest Medical, Aylesford, UK), steam-cleaning, 
and double-strength hypochlorite solution (2,000ppm; Chlor Clean) followed by 
hydrogen peroxide misting (OxyPharm, Sandbach, UK) at 12% concentration. After 
cleaning was assessed as adequate by an infection control nurse multiple 
macroscopically clean touch-points throughout the side room were then sampled 
(Table 1), as described previously.5 Swabs were tested using the Cepheid Xpert 
Norovirus PCR (Cepheid Inc, Sunnyvale, CA, USA).6 Norovirus was detected by 
PCR from the environmental sampling after the enhanced clean. A second room 
clean was ordered, which included an additional step of UV irradiation (Hygiene 
Solutions, Kings Lynn, UK) (Table 1). This time no detectable norovirus was detected 
on environmental sampling and the bed space was reopened.  
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 4
In immunocompromised adults, norovirus gastroenteritis can become chronic 
and persist for weeks to years,1 as in the case described here at QEHB. Bok et al 
suggested that it is not clear whether noroviruses are transmissible to 
immunocompetent adults from patients with chronic viral shedding, questioning the 
virulence of noroviruses in this setting.1 However, in our experience we saw 
secondary cases throughout a chronic carrier’s inpatient stays over a 10-month 
period, probably including immunocompetent staff members. 
 
Prior room occupancy is the single biggest risk factor for acquiring healthcare 
associated micro-organisms.7 Utilising a norovirus PCR to assess the environment 
after cleaning may be an important tool in providing assurance that it is safe to admit 
patients into bedspaces previously occupied by norovirus shedders. 
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TABLE 
Table 1. Norovirus PCR results from environmental sampling of 7 surfaces in the patient’s room using polywipe sponges (surface 
area ~30cm2).  
Key: + = positive PCR for norovirus; - = negative PCR for norovirus. The enhanced room clean comprised of a detergent/ 
disinfectant (1,000ppm; Chlor Clean), steam-cleaning, double-strength hypochlorite solution (2,000ppm; Chlor Clean) followed by 
hydrogen peroxide misting (OxyPharm) at 12% concentration. The only difference with the enhanced clean with UV irradiation was 
the addition of UV (Hygiene Solutions, UK) after the enhanced clean of the side room. 
Surface tested Enhanced Clean – Norovirus PCR result Enhanced Clean with UV – Norovirus PCR result 
Surface areas in vicinity of patient  
Bed Frame + - 
Table + - 
Cardiac monitor - - 
Floor - - 
Communal area surfaces tested  
Bathroom handles + - 
Door handles - - 
Fridge + - 
